Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000213943 | SCV000273950 | likely benign | Hereditary cancer-predisposing syndrome | 2015-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001084726 | SCV000628806 | likely benign | Neurofibromatosis, type 1 | 2024-10-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000681195 | SCV000808653 | likely benign | not provided | 2019-05-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001084726 | SCV002561344 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |